Clinical Trial Detail

NCT ID NCT01849874
Title A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Array BioPharma
Indications

ovarian carcinoma

peritoneal carcinoma

fallopian tube carcinoma

Therapies

Binimetinib

Age Groups: adult

No variant requirements are available.